PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30

PHIBRO ANIMAL HEALTH CORP

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 26, 2026

$39.34+0.52 (+1.34%)

Close on Oct 19, 2026

Community

Notes and questions about Phibro Animal Health from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Phibro Animal Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PAHC.

Revenue growth17.1% · median 9.3%

Gross margin33.8% · median 55.4%

Operating margin12.8% · median 15.4%

Net margin6.6% · median 11.1%

Advertisement
300 × 250